Treatment-resistant depression (TRD) is a classification applied when standard antidepressant medication has not produced the expected improvement.
The word “resistant” describes how the depression responded to a specific medication protocol. It does not describe effort or personal failure.
Roughly 30% of people diagnosed with major depressive disorder meet this classification, according to Johns Hopkins Medicine.
What Qualifies As Treatment-Resistant Depression?
Treatment-resistant depression is diagnosed when a person with major depressive disorder has completed at least two adequate antidepressant trials without meaningful symptom improvement.
Major depressive disorder is defined in the DSM-5-TR, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, which is the reference clinicians in the United States use for diagnosis. Understanding depression as the parent diagnosis clarifies why TRD is not a separate condition.
TRD is a classification applied to depression based on treatment response, which is why depression therapy approaches often shift once the classification applies.
The threshold has specific components, and all of them must be met before the classification applies.
- Two Failed Medication Trials: You have taken at least two different antidepressants without significant symptom relief.
- Adequate Dose Reached: Each medication was taken at a therapeutic dose, not a starting or subtherapeutic dose (too low to produce a clinical effect).
- Adequate Duration Completed: Each trial lasted six to eight weeks, long enough for the medication to take full effect.
- Diagnosis Confirmed: The original diagnosis of major depressive disorder has been reviewed and holds up.
- Partial Response Distinguished: A partial response (some symptom improvement without full remission) counts differently than no response at all.
That last point matters more than most people realize.
If you felt 30% better on a medication, that is a partial response, which points toward a different next step than feeling nothing change.
What Does TRD Feel Like?
Treatment-resistant depression feels like standard depression with a second layer stacked on top of it.
The original symptoms continue. Alongside them sits a growing belief that treatment itself does not work.
You may find yourself going through the motions of care, meaning appointments, refills, and dose adjustments, while privately expecting none of it to help.
Here is what tends to show up.
- Persistent Low Mood: Sadness or emptiness that holds steady across weeks and multiple medication changes.
- Continued Loss of Interest: Activities that once mattered still produce nothing, including activities a person forced themselves back into.
- Unresolved Sleep Disruption: Early waking, difficulty falling asleep, or sleeping heavily without feeling rested.
- Ongoing Fatigue: Physical heaviness that does not lift with rest and does not track with activity level.
- Hopelessness About Treatment Itself: A specific kind of discouragement aimed at the process of getting better, separate from general hopelessness.
- Self-Blame For Non-Response: The conclusion that the medication worked fine and the person is the reason it failed.
Those final two symptoms rarely appear in medical descriptions of TRD, yet they are frequently the ones that most directly determine if a person continues to seek care.
In high-performance areas like San Jose and Silicon Valley, where professional identity is closely tied to productivity, the self-blame that follows failed medication trials often intensifies. If burnout is layered on top of your depression, the two can reinforce each other in ways that make both harder to treat alone.
Anxiety frequently sits alongside all of this. Unmanaged anxiety symptoms can independently blunt how well an antidepressant performs, which is one reason a full symptom picture matters more than a single diagnosis label.
When Your Antidepressant Stops Working
Start by bringing the pattern to the provider who prescribed the medication, and do not adjust anything independently.
An antidepressant that helped and then stopped helping is common, documented, and workable. The response is a structured reassessment rather than a complete restart.
These five steps cover what to do first.
- Do Not Stop Medication On Your Own: Stopping an antidepressant abruptly can produce discontinuation symptoms (withdrawal-like effects including dizziness, nausea, and mood instability that can occur when stopping an antidepressant abruptly). Any change runs through the prescribing provider.
- Document The Pattern: Note when the medication helped, when it stopped, and what changed around that time. Specific dates give a prescriber something concrete to work with.
- Request A Diagnostic Review: Ask the provider to re-examine the diagnosis. Bipolar II disorder (a condition involving depressive episodes and milder manic episodes that are often missed), persistent depressive disorder (a chronic, lower-grade form of depression lasting two or more years), unprocessed trauma, and thyroid dysfunction each produce depressive symptoms that standard antidepressants do not fully address.
- Ask About Next-Step Options: Prescribers may discuss switching medication class, adding a second medication, or referring to interventional psychiatry (a branch of psychiatric care that uses device-based and medication-based treatments beyond standard antidepressants) for transcranial magnetic stimulation (TMS), esketamine, ketamine, or electroconvulsive therapy (ECT). These are medical treatments delivered by physicians and psychiatric providers, not by psychotherapists.
- Add or Reassess Therapy: Adding structured therapy ensures the treatment plan reaches what medication alone cannot.
If you are experiencing thoughts of self-harm, call or text 988 to reach the Suicide and Crisis Lifeline, available 24 hours a day.
Reassessing therapy does not mean repeating what was already tried. It means looking honestly at what the previous approach targeted and what it missed.
Clear goals set at the outset give both the client and the clinician a way to tell, in weeks rather than months, if the new direction is moving.
How Does Therapy Adapt for TRD?
Therapy for treatment-resistant depression begins with a reassessment rather than a modality.
A person arriving after two or three failed medication trials does not receive a standard-issue treatment plan.
The clinical question shifts from “how do we treat depression” to “what has this depression not responded to, and why.”
A Fresh Clinical Reassessment
The first sessions examine what previous treatment targeted and what it did not reach.
Clinicians look for patterns pointing toward a different diagnosis, including mood elevation suggesting bipolar II disorder, executive functioning difficulty (trouble with planning, organizing, and completing tasks) being read as the low motivation depression produces, or trauma symptoms presenting as flat mood.
Pacific Coast Therapy clinicians work across a broad range of clinical presentations, allowing reassessment to move in any direction the presentation indicates, rather than back toward the original label.
CBT for Fixed Thought Patterns
Cognitive behavioral therapy targets the fixed negative thought patterns that antidepressant medication does not directly address.
Dr. Aaron Beck developed CBT around the relationship among thoughts, emotions, and behavior.
For someone with treatment-resistant depression, the work often centers on the rigid thought patterns that failed medication trials reinforce.
DBT for Chronic Distress
Dialectical behavior therapy builds tolerance for emotional states that have been present for years rather than months.
Dr. Marsha Linehan developed DBT to teach concrete skills in distress tolerance, emotion regulation, and interpersonal effectiveness.
This approach fits people whose depression carries intense emotional swings or sustained difficulty regulating their internal state, both of which medication alone rarely resolves.
EMDR for Underlying Trauma
EMDR therapy is a trauma-reprocessing modality that addresses unresolved traumatic memory driving a depressive presentation.
When trauma sits underneath depression, antidepressants may reduce symptom intensity without touching the source.
EMDR works directly on how the traumatic memory is stored and processed, which changes what the depression is drawing from.
IFS for Self-Criticism
Internal family systems therapy works with the entrenched self-criticism that repeated treatment failure tends to intensify.
IFS treats the internal critic as one part of a larger system rather than as the truth about a person.
For clients who have carried years of self-blame for not getting better, this approach separates the criticism from the identity it attached itself to.
Getting Started With Support That Fits
Pacific Coast Therapy matches each client with a clinician based on presentation, goals, and personality fit, which matters more after previous treatment has not worked.
Our team practices across offices in Campbell and Santa Cruz, serving San Jose, Silicon Valley, and the rest of California through online sessions. Clients looking for depression therapy serving the San Jose area can start with either location or online.
Every match begins with a complimentary 15-minute call to assess fit and match you with the right clinician.
Reaching out after repeated treatment attempts is a meaningful step, and our process is designed to meet it with the right clinical fit. Reach out to get matched with a clinician who understands treatment-resistant depression and the frustration that comes with it.
FAQs
What qualifies as treatment-resistant depression?
TRD is classified when at least two antidepressants have been tried at adequate doses for adequate durations without meaningful improvement. See the criteria section above for the specific thresholds.
What does treatment-resistant depression feel like?
Treatment-resistant depression feels like ongoing depressive symptoms paired with discouragement aimed at treatment itself.
Low mood, loss of interest, disrupted sleep, and fatigue continue through medication changes.
Why am I still depressed on antidepressants?
Several factors can prevent an antidepressant from working, including an incomplete diagnosis, an untreated co-occurring condition, or a medical issue such as thyroid dysfunction.
Some people metabolize certain medications differently, which affects how much of the drug reaches its target. A prescribing provider can evaluate which of these applies.
What do doctors do when antidepressants don’t work?
Prescribers typically switch to a different class of antidepressant or use augmentation (adding a second medication to boost the effect of the first).
If those steps do not produce a response, a physician may discuss transcranial magnetic stimulation, esketamine, ketamine, or electroconvulsive therapy. All of these are medical treatments delivered by physicians and psychiatric providers, not by psychotherapists.
Can therapy help when medication has not?
Yes. Psychotherapy works through different mechanisms than medication, and research supports combining the two for persistent depression.
Therapy addresses thought patterns, emotional regulation, unresolved trauma, and relationship difficulty that medication does not directly reach. Pacific Coast Therapy offers in-person sessions and online therapy in California, so care remains available regardless of location.
How long does it take to know if a treatment is working?
Antidepressants generally need a full trial of six to eight weeks before their effect can be properly evaluated, though some people notice initial changes earlier.
Therapy timelines vary by modality and presentation, and setting clear goals early makes progress easier to evaluate.
Is there hope for treatment-resistant depression?
Yes. A classification of treatment-resistant depression indicates that two specific medications did not work, not that all treatment has been exhausted.
Many people achieve remission (a sustained period in which depressive symptoms are no longer clinically significant) after a diagnostic reassessment, a different modality, or a combination of medication and therapy that had not yet been tried.
